Molsidomine

From Infogalactic: the planetary knowledge core
Jump to: navigation, search
Molsidomine
Molsidomine.svg
Names
IUPAC name
1-Ethoxy-N-(3-morpholino-5-oxadiazol-3-iumyl)methanimidate
Identifiers
25717-80-0 YesY
ChEMBL ChEMBL1256353 N
ChemSpider 4090 YesY
Jmol 3D model Interactive image
KEGG D01320 YesY
PubChem 5353788
UNII D46583G77X YesY
  • InChI=1S/C9H14N4O4/c1-2-16-9(14)10-8-7-13(11-17-8)12-3-5-15-6-4-12/h7H,2-6H2,1H3 YesY
    Key: XLFWDASMENKTKL-UHFFFAOYSA-N YesY
  • InChI=1/C9H14N4O4/c1-2-16-9(14)10-8-7-13(11-17-8)12-3-5-15-6-4-12/h7H,2-6H2,1H3
    Key: XLFWDASMENKTKL-UHFFFAOYAC
  • [O-]C(OCC)=Nc2on[n+](N1CCOCC1)c2
Properties
C9H14N4O4
Molar mass 242.23 g/mol
Pharmacology
ATC code C01DX12
Vapor pressure {{{value}}}
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
N verify (what is YesYN ?)
Infobox references

Molsidomine is an orally active, long acting vasodilating drug. Molsidomine is metabolized in the liver to the active metabolite linsidomine. Linsidomine is an unstable compound that releases nitric oxide (NO) upon decay as the actual vasodilating compound.[1]

Release of nitric oxide[2]

Chemistry

Molsidomine as well as linsidomine are sydnone imines, a class of mesoionic heterocyclic aromatic chemical compounds.

Synthesis

A mesoionic sydnone is active as an antianginal agent.

File:Molsidomine synthesis.svg
Molsidomine synthesis:[3]

Its synthesis starts by reacting 1-aminomorpholine with formaldehyde and hydrogen cyanide to give 2. Nitrosation gives the N-nitroso analog (3) which cyclizes to the sydnone (4) on treatment with anhydrous acid. Formation of the ethyl urethane is then made possible by reacting Linsidomine with Ethyl chloroformate.

See also

References

  1. Lua error in package.lua at line 80: module 'strict' not found.
  2. Lua error in package.lua at line 80: module 'strict' not found.
  3. Chemical & pharmaceutical bulletin 19(1), 72-79, 1971-01-25.


<templatestyles src="Asbox/styles.css"></templatestyles>